Global Med Technologies(R), Inc. Announces 300th Milestone Next Stop: 500 Installations SafeTrace(R) and SafeTrace Tx(R) Installations Reach Projected Goals DENVER, Jan. 14 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the installation of its products, SafeTrace(R) donor management system and SafeTrace Tx(R) transfusion management system, in over 300 blood centers, hospitals, hospital networks and centralized transfusion services, both domestically and internationally. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "Global Med Technologies has reached yet another of its projected milestones -- contracting and implementing our donor management and transfusion management software products in over 300 facilities," said Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies. Dr. Ruxin added, "Quality and safety have been the foundation stones for our success in providing high quality products and services through continuous improvement. Our success is proven by our loyal customer base, as well as our growing list of prestigious new clients in the United States and internationally." Dr. Ruxin continued, "Our next milestone is 500 sites, and we have more than enough prospects in the pipeline to see that business materializing in the foreseeable future. In addition we have our sights set on achieving critical mass, meaning that our recurring maintenance revenue will cover all of our expenses. Thereafter, the vast majority of our new sales revenues will drop to the bottom line. That will mean substantial profitability for Global Med." Wyndgate Technologies developed the SafeTrace Tx advanced transfusion management system in collaboration with the Institute for Transfusion Medicine in Pittsburgh, PA. SafeTrace Tx is a Microsoft(R) Windows(R)-based, feature-rich hospital transfusion service management system that is uniquely designed and proven to fully support enterprise-wide centralized transfusion services management, in addition to its demonstrated success in the small hospital/laboratory environment. SafeTrace Tx's features include complete patient, specimen, order and test management, along with consolidated inventory management and tracking. SafeTrace Tx has many built-in safety features, such as special needs capture by diagnosis, product suitability determination, comprehensive compatibility routines and special donation tracking. SafeTrace Tx can assist in enhancing the efficiency of operations and streamlining workflow through advanced functionality, such as electronic and remote crossmatching, automatic charge capture, interfaces with automated patient testing instruments, and integration with the hospital and laboratory information systems. Wyndgate also developed SafeTrace, a comprehensive donor management system built on an Oracle relational database management system. Its features include donor management from recruitment and collection through testing, labeling and final distribution. The efficiency of the donor management operation can be enhanced by utilizing the Mobile Donor Management module to manage mobile donor registration and collections. Additional functionality beyond the core donor management system includes Donor Web Scheduler, which enables donors to conveniently schedule donor appointments via the Web, and the new Web-Based Report Server, enabling clients to generate custom reports. Current Wyndgate clients manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. The combination of SafeTrace and SafeTrace Tx provides Vein-to-Vein(R) tracking from donor collection to patient transfusion. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Press, Wm. Scott Dustin, Vice President of Sales and Marketing, +1-916-404-8415, , or Investors, Tom Marcinek, President and COO, +1-916-404-8413, Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright